ADPT

Adaptive Biotechnologies Q2 Loss decreases, beats estimates

(RTTNews) - Adaptive Biotechnologies (ADPT) reported Loss for second quarter that decreased from last year and beat the Street estimates.

The company's earnings came in at -$47.81 million, or -$0.33 per share. This compares with -$52.05 million, or -$0.37 per share, in last year's second quarter.

Analysts on average had expected the company to earn -$0.35 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company's revenue for the quarter rose 12.1% to $48.93 million from $43.66 million last year.

Adaptive Biotechnologies earnings at a glance (GAAP) :

-Earnings (Q2): -$47.81 Mln. vs. -$52.05 Mln. last year. -EPS (Q2): -$0.33 vs. -$0.37 last year. -Analyst Estimates: -$0.35 -Revenue (Q2): $48.93 Mln vs. $43.66 Mln last year.

-Guidance: Full year revenue guidance: $205 mln to $215 mln

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.